Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice

Overview of attention for article published in Frontiers in immunology, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

patent: 2 patents

f1000: 1 research highlight platform

Readers on

mendeley: 42 Mendeley

Summary Patents Research highlights

So far, Altmetric has seen 2 patents that reference this research output.

COVERSIN FOR THE TREATMENT OF AUTOIMMUNE BLISTERING DISEASES

Application EP-4275696-A1

European Patent Office

COVERSIN FOR THE TREATMENT OF AUTOIMMUNE BLISTERING DISEASES

Application WO-2018193122-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.